Stocks & ETFs Screener: 200+ results (Biotechnology)

Symbol	Industry	Market Cap	Fund. Score	Div. Score	Tech. Score	P/E	Return 12m vs S&P 500
ABBV AbbVie	Biotechnology Biologics, Immunology, Oncology	406B	48.0%	68.7%	84.4%	175	12.0%
AMGN Amgen	Biotechnology Rheumatoid Arthritis, Psoriasis	181B	82.1%	67.8%	56.7%	26.0	10.6%
GILD Gilead Sciences	Biotechnology Antivirals, Oncology, Hepatitis	155B	83.2%	65.3%	86.8%	19.4	23.7%
VRTX Vertex	Biotechnology Cystic Fibrosis, Sickle Cell, Beta	109B	87.0%	-	20.2%	30.0	-19.0%
REGN Regeneron	Biotechnology Eylea, Dupixent, Libtayo	78.1B	75.7%	14.8%	-4.55%	17.7	-9.02%
ALNY Alnylam	Biotechnology RNAi Therapeutics, Patisiran	57.4B	61.7%	-	85.7%	-	52.7%
ARGX argenx	Biotechnology Antibody,Autoimmune,Therapy,FcRn,Ig..	57.2B	71.2%	-	80.5%	39.2	30.0%
HLN Haleon	Biotechnology Toothpaste, Vitamins, Pain-Relief	44.0B	60.1%	53.3%	46.4%	22.3	-11.0%
INSM Insmed	Biotechnology Inhaled Antibiotic, DPP1	42.4B	32.5%	-	86.9%	-	135%
ONC BeiGene	Biotechnology BTK-Inhibitor, Anti-PD-1	38.7B	64.5%	-	64.3%	659	43.8%
NTRA Natera	Biotechnology Prenatal Screening, Carrier	31.8B	47.9%	-	70.0%	-	22.5%
BIIB Biogen	Biotechnology Multiple Sclerosis Therapies	25.9B	66.7%	-	-33.2%	16.1	-0.91%
BNTX BioNTech SE	Biotechnology Oncology Vaccines,Checkpoint	24.7B	13.6%	1.0%	-54.4%	-	-26.0%
22UA BioNTech SE	Biotechnology Cancer Vaccines, mRNA Therapies	23.9B	17.5%	1.0%	-64.7%	-	-32.9%
UTHR United Therapeutics	Biotechnology Treprostinil, Treprostinil	22.0B	92.2%	-	66.7%	18.1	12.4%
INCY Incyte	Biotechnology JAKAFI, MONJUVI, PEMAZYRE	19.9B	90.2%	-	36.0%	17.2	21.9%
GMAB Genmab AS	Biotechnology Antibody, Cancer, Lymphoma	18.8B	78.6%	-	-1.13%	13.4	31.3%
BIM Biomerieux	Biotechnology Diagnostic, Instruments, Reagents	15.0B	78.1%	60.3%	29.7%	34.6	-3.35%
ROIV Roivant Sciences	Biotechnology Antibody, Small-Molecule, Inhaled	14.1B	31.3%	-	82.7%	-	43.2%
NBIX Neurocrine	Biotechnology Movement, Endocrine	14.1B	85.8%	-	40.7%	33.6	4.23%
RVMD Revolution	Biotechnology RAS Inhibitors, Companion	13.7B	24.6%	-	59.5%	-	15.3%
MDGL Madrigal	Biotechnology Rezdiffra, Liver Therapy, MASH	13.4B	55.5%	-	83.2%	-	57.8%
EXAS EXACT Sciences	Biotechnology Colorectal, Breast, Colon	13.2B	47.5%	-	33.7%	-	43.2%
ASND Ascendis Pharma AS	Biotechnology Growth Hormone	12.9B	35.9%	-	77.1%	-	34.1%
BBIO BridgeBio Pharma	Biotechnology ATTR Medication, FGFR Inhibitor	12.5B	48.7%	-	83.1%	-	127%
SMMT Summit Therapeutics	Biotechnology Antibody, Immunotherapy, Oncology	12.3B	43.1%	-	49.9%	-	-18.1%
ERF Eurofins	Biotechnology Testing, Laboratory, Services	12.1B	70.1%	2.73%	16.7%	26.0	10.2%
IONS Ionis	Biotechnology Triglyceride, Amyloidosis, SMA	12.1B	19.7%	0.21%	70.0%	-	101%
EXEL Exelixis	Biotechnology Cabozantinib, Cobimetinib	11.3B	93.1%	-	81.1%	17.7	7.10%
RNA Avidity Biosciences	Biotechnology Antibody-Oligonucleotide	10.7B	33.3%	-	80.6%	-	43.8%
BMRN Biomarin	Biotechnology Enzyme replacement therapy	10.4B	86.1%	-	-70.4%	20.1	-26.1%
MRNA Moderna	Biotechnology Respiratory Vaccines, Latent	9.44B	22.3%	-	-85.9%	-	-49.8%
HALO Halozyme	Biotechnology Enzyme, Cancer, Immunodeficiency	8.26B	92.1%	-	51.9%	14.8	30.5%
ABVX Abivax American	Biotechnology Obefazimod, Immunoregulatory	8.19B	38.7%	-	76.5%	-	1,178%
ABVX Abivax	Biotechnology Drug, Phase3, Ulcerative, Crohns	8.08B	42.5%	-	69.5%	-	1,110%
CYTK Cytokinetics	Biotechnology Cardiac Activator, Skeletal	7.76B	35.7%	-	39.8%	-	13.6%
NUVL Nuvalent	Biotechnology ROS1 Inhibitor, ALK Inhibitor	7.70B	28.9%	-	69.7%	-	-1.89%
GRFS Grifols	Biotechnology Immunoglobulin, Albumin	7.65B	68.4%	40.8%	19.8%	13.8	-3.73%
MRUS Merus BV	Biotechnology Bispecific Antibodies, BIZENGRI	7.28B	28.7%	-	92.1%	-	86.0%
CDTX Cidara Therapeutics	Biotechnology Antifungal, Antiviral, Oncology	6.90B	23.5%	-	78.0%	-	847%
RYTM Rhythm	Biotechnology Setmelanotide, Rare Obesity, MC4R	6.79B	43.0%	-	93.2%	-	50.2%
PCVX Vaxcyte	Biotechnology Pneumococcal, Streptococcus	6.25B	27.0%	-	-10.4%	-	-54.0%
RGC Regencell	Biotechnology Traditional Chinese Medicine	6.24B	36.4%	-	78.2%	-	6,036%
PTCT PTC Therapeutics	Biotechnology Translarna, Emflaza, Upstaza	6.07B	65.6%	-	60.6%	8.93	66.4%
KRYS Krystal Biotech	Biotechnology Gene, Therapy, Topical, Wound, Skin	5.93B	89.1%	-	62.0%	30.7	-3.32%
ARWR Arrowhead	Biotechnology Plozasiran, Olpasiran, Fazirsiran	5.59B	33.1%	-	37.3%	-	92.1%
PTGX Protagonist	Biotechnology Peptide, Hematology, Inflammation	5.34B	64.0%	-	89.4%	129	74.4%
COGT Cogent Biosciences	Biotechnology Kinase Inhibitor, FGFR Inhibitor	5.33B	49.3%	-	65.2%	-	267%
ACLX Arcellx	Biotechnology Anitocabtagene Autoleucel	5.24B	40.5%	-	63.6%	-	-28.4%
LEGN Legend Biotech	Biotechnology CAR-T, Oncology, Myeloma	5.20B	30.1%	-	-51.0%	-	-44.5%
TGTX TG Therapeutics	Biotechnology Anti-CD20 Antibody, BTK Inhibitor	5.09B	67.4%	-	39.7%	11.6	-16.9%
ALKS Alkermes	Biotechnology Schizophrenia, Bipolar, Alcohol	4.83B	89.7%	-	10.7%	14.6	-11.8%
CRSP Crispr Therapeutics	Biotechnology Gene-Edited Cell Therapy, CAR T	4.79B	31.3%	-	9.42%	-	-8.74%
KYMR Kymera Therapeutics	Biotechnology IRAK4, STAT6, TYK2, Protein	4.65B	29.0%	-	60.2%	-	26.1%
APGE Apogee	Biotechnology Monoclonal Antibody, Atopic	4.53B	35.0%	-	61.2%	-	37.1%
CELC Celcuity	Biotechnology Cancer Test, Therapy Candidate	4.36B	24.7%	-	78.3%	-	580%
NAMS NewAmsterdam	Biotechnology Obicetrapib, Ezetimibe, CETP	4.34B	27.1%	-	82.4%	-	73.5%
VKTX Viking Therapeutics	Biotechnology VK2809, VK2735, VK5211, VK0214	4.27B	40.8%	-	48.3%	-	-42.1%
PRAX Praxis Precision	Biotechnology Ulixacaltamide, Vormatrigine	4.25B	30.5%	-	46.0%	-	107%
BLTE Belite Bio	Biotechnology Oral Therapy, Stargardt	4.21B	32.1%	-	86.1%	-	67.3%
ADMA ADMA Biologics	Biotechnology IVIG, Immune Globulin, Hepatitis	4.10B	85.0%	-	41.6%	20.0	-23.7%
IMVT Immunovant	Biotechnology Monoclonal Antibodies, Autoimmune	4.09B	25.8%	-	17.4%	-	-28.2%
CRNX Crinetics	Biotechnology Paltusotine, Atumelnant, CRN09682	4.07B	21.7%	-	45.9%	-	-30.5%
INDV Indivior Ordinary	Biotechnology Suboxone, Sublocade, Subutex, Opvee	4.03B	74.1%	2.63%	61.6%	32.9	157%
CNTA Centessa	Biotechnology Sleep Disorder Drug	4.02B	33.3%	-	71.7%	-	43.3%
ACAD ACADIA	Biotechnology Parkinsons Psychosis Drug, Rett	3.99B	86.7%	-	53.0%	15.2	32.6%
LGND Ligand	Biotechnology Infectious, Oncology, Nephrology	3.92B	52.2%	0.14%	82.7%	87.7	46.4%
SRRK Scholar Rock	Biotechnology Monoclonal Antibodies, Inhibitor	3.88B	25.9%	-	35.6%	-	-1.55%
GRAL GRAIL	Biotechnology Cancer Screening, Diagnostic Aid	3.65B	40.1%	-	91.6%	-	450%
ARQT Arcutis	Biotechnology Topical Cream, Topical Foam, JAK1	3.61B	41.9%	-	50.8%	-	130%
MIRM Mirum	Biotechnology LIVMARLI, Cholbam, Chenodal	3.55B	48.2%	-	91.9%	-	36.5%
IRON Disc Medicine	Biotechnology Porphyria Drug, Anemia Drug	3.50B	36.3%	-	46.4%	-	26.4%
VCYT Veracyte	Biotechnology Thyroid, Prostate, Bladder	3.48B	63.3%	-	20.5%	116	-3.17%
CGON CG Oncology	Biotechnology Oncolytic Immunotherapy	3.42B	32.2%	-	26.4%	-	14.5%
MLYS Mineralys	Biotechnology Phase II Inhibitor, Oral	3.31B	31.1%	-	74.5%	-	188%
RARE Ultragenyx	Biotechnology Biologic, Gene Therapy, Antibody	3.24B	36.5%	-	-52.3%	-	-38.9%
XENE Xenon	Biotechnology Kv7 Opener, Phase 3, Epilepsy	3.18B	29.2%	-	22.0%	-	-10.3%
KNSA Kiniksa	Biotechnology ARCALYST, Vixarelimab, KPL-387	3.13B	67.0%	-	92.4%	91.7	65.9%
IDYA Ideaya Biosciences	Biotechnology Oncology, Kinase, Inhibitor, ADC	3.11B	22.9%	-	59.9%	-	15.7%
TVTX Travere	Biotechnology Medication, Tablets, Enzyme	3.11B	27.7%	-	41.4%	-	68.8%
FOLD Amicus Therapeutics	Biotechnology Galafold, Pombiliti, Opfolda, Gene	2.95B	52.6%	-	-28.6%	-	-12.4%
DYN Dyne Therapeutics	Biotechnology Therapeutics, Muscular Dystrophy	2.94B	29.6%	-	18.6%	-	-40.8%
CPRX Catalyst	Biotechnology Firdapse, Fycompa, Ruzurgi, Agamree	2.86B	91.5%	-	23.9%	13.6	-8.71%
DNLI Denali Therapeutics	Biotechnology RIPK1 Inhibitor, LRRK2 Inhibitor	2.78B	25.0%	-	-58.2%	-	-32.9%
VRDN Viridian	Biotechnology Monoclonal Antibody, Thyroid Eye	2.77B	46.9%	-	28.6%	-	26.3%
APLS Apellis	Biotechnology Therapeutic, Complement	2.48B	76.8%	-	-62.6%	54.5	-45.0%
RCUS Arcus Biosciences	Biotechnology HIF-2a-Inhibitor	2.47B	29.5%	-	-17.9%	-	40.8%
SLNO Soleno Therapeutics	Biotechnology Diazoxide, Choline, Tablet, Rare	2.42B	41.4%	-	61.9%	-	-22.8%
EWTX Edgewise	Biotechnology Muscle Disorder Therapies	2.40B	29.8%	-	16.7%	-	-31.0%
NUVB Nuvation Bio	Biotechnology Oncology Pipeline Drug Candidates	2.40B	35.6%	-	60.8%	-	141%
NNNN Anbio	Biotechnology Antigen Tests, Immunoassay	2.32B	66.8%	-	85.0%	858	250%
BEAM Beam Therapeutics	Biotechnology Base-Editing Therapeutics, Sickle	2.25B	28.0%	-	-56.0%	-	-19.9%
ZLAB Zai Lab	Biotechnology Oncology, Immunology	2.22B	30.9%	-	-48.3%	-	-38.2%
RXRX Recursion	Biotechnology Drug Discovery Platform	2.17B	30.1%	-	-70.9%	-	-39.8%
AUPH Aurinia	Biotechnology Immunosuppressant, Lupus	2.12B	93.8%	-	61.3%	28.8	61.0%
IBRX Immunitybio	Biotechnology Immunotherapy, Vaccine, Cytokine	2.12B	65.8%	-	-74.8%	-	-63.7%
GPCR Structure	Biotechnology GSBR-1290, ACCG-2671, ANPA-0073	2.08B	31.2%	-	25.8%	-	-11.7%
GLPG Galapagos	Biotechnology CAR-T, Oncology, Immunology	2.03B	25.3%	-	-17.2%	-	-12.4%
GLPG Galapagos	Biotechnology Medicine, Oncology, Immunology	2.02B	37.8%	-	-1.60%	-	-3.64%
VCEL Vericel Ord	Biotechnology Cartilage, Skin, Burn, Autologous	2.00B	61.7%	-	-0.83%	152	-39.2%
IMCR Immunocore Holdings	Biotechnology Oncology Immunotherapy	1.99B	41.7%	-	3.45%	-	6.40%
SION Sionna	Biotechnology Galicaftor, Navocaftor, SION-109	1.95B	37.1%	-	91.2%	-	115%
MESO Mesoblast	Biotechnology Stem-Cell Therapy, Inflammation	1.94B	31.5%	-	41.1%	-	30.6%
ZBIO Zenas BioPharma	Biotechnology Bifunctional Monoclonal Antibody	1.91B	31.4%	-	85.6%	2.61	200%
SYRE Spyre Therapeutics	Biotechnology Monoclonal Antibodies	1.88B	28.5%	-	22.0%	-	-6.68%
SRPT Sarepta	Biotechnology RNA Therapeutics, Duchenne	1.83B	30.3%	-	-76.8%	-	-86.8%
OLMA Olema	Biotechnology Palazestrant, OP-3136, KAT6	1.82B	33.9%	-	59.9%	-	142%
VERA Vera Therapeutics	Biotechnology Atacicept, Mab, Dual-Inhibitor	1.82B	23.4%	3.50%	17.2%	-	-40.6%
ZYME Zymeworks Common	Biotechnology Zanidatamab, Bispecific Antibody	1.80B	28.6%	-	66.5%	-	65.0%
DNTH Dianthus	Biotechnology Monoclonal Antibody, DNTH103	1.78B	27.9%	-	46.3%	-	60.8%
JANX Janux Therapeutics	Biotechnology JANX007, JANX008, TRACTr, TRACIr	1.73B	28.6%	-	9.93%	-	-34.9%
QURE Uniqure	Biotechnology Gene Therapy, Hemophilia Treatment	1.73B	36.0%	-	19.7%	-	300%
CLDX Celldex	Biotechnology Monoclonal Antibody, Bispecific	1.72B	40.4%	-	-22.1%	-	-16.4%
ALVO Alvotech	Biotechnology Biosimilar, Autoimmune, Oncology	1.72B	36.6%	-	-45.5%	24.0	-61.6%
PHVS Pharvaris BV	Biotechnology Bradykinin, Antagonist	1.61B	24.4%	-	72.6%	-	7.91%
IMNM Immunome	Biotechnology Antibody, Oncology, Bispecific	1.61B	45.2%	-	57.4%	-	20.4%
STOK Stoke Therapeutics	Biotechnology STK-002,Zorevunersen,ASOs,TANGO,Gen..	1.60B	73.3%	-	66.8%	41.1	128%
TWST Twist Bioscience	Biotechnology Synthetic DNA, Gene Fragments	1.59B	35.7%	-	-35.3%	-	-42.9%
MNKD MannKind	Biotechnology Inhaled Insulin, Insulin Delivery	1.56B	64.2%	-	-4.59%	50.7	-29.2%
AGIO Agios Pharm	Biotechnology Mitapivat, Tebapivat, AG-181	1.54B	34.6%	-	-2.47%	-	-56.9%
SNDX Syndax	Biotechnology Menin Inhibitor, CSF-1R Antibody	1.52B	36.6%	-	-11.9%	-	4.76%
MEDCL Medincell	Biotechnology Schizophrenia, Postoperative Pain	1.48B	53.3%	-	81.8%	-	40.0%
BCRX BioCryst	Biotechnology Antiviral Injection, Oral HAE	1.47B	71.6%	-	-41.3%	-	-17.6%
ATAI ATAI Life Sciences	Biotechnology Psychedelic, Intranasal, Oral	1.38B	37.9%	-	32.1%	-	88.7%
PGEN Precigen	Biotechnology UltraCAR-T, AdenoVerse, PRGN-3005	1.36B	34.7%	-	55.9%	-	258%
TNGX Tango Therapeutics	Biotechnology PRMT5 Inhibitor, Glioblastoma	1.35B	33.2%	-	39.6%	-	130%
DVAX Dynavax	Biotechnology Hepatitis Vaccine, Adjuvant	1.34B	38.0%	-	-29.8%	-	-22.9%
ARDX Ardelyx	Biotechnology IBS-C Therapy, Phosphate	1.34B	33.6%	-	45.6%	-	-9.28%
ORKA Oruka Therapeutics	Biotechnology Monoclonal Antibody	1.33B	28.8%	1.0%	49.9%	-	30.9%
BTX BlackRock	Biotechnology Technology, Private, Equity	1.32B	33.5%	87.9%	13.5%	51.8	-15.6%
BHVN Biohaven	Biotechnology Troriluzole, Taldefgrobep	1.29B	31.9%	-	-62.3%	-	-82.2%
NRIX Nurix Therapeutics	Biotechnology BTK Degrader, IRAK4 Degrader	1.29B	35.0%	-	-16.0%	-	-29.5%
UPB Upstream Bio	Biotechnology Verekitug, Asthma, Rhinosinusitis	1.26B	38.0%	-	61.5%	-	14.6%
IMTX Immatics	Biotechnology TCR-Engineered Cell Therapy, TCR	1.24B	22.0%	-	11.5%	-	16.8%
MBX MBX Biosciences	Biotechnology Hypoparathyroidism, Hypoglycemia	1.22B	31.8%	-	62.2%	3.53	40.4%
RLAY Relay Therapeutics	Biotechnology PI3Ka Inhibitor, Estrogen	1.17B	47.4%	-	-27.5%	-	45.6%
URGN UroGen Pharma	Biotechnology Jelmyto, UGN-102, UGN-103	1.16B	48.5%	-	69.1%	-	102%
TSHA Taysha Gene	Biotechnology Gene, Therapy, AAV, CNS, Monogenic	1.15B	45.7%	-	54.6%	-	41.0%
XNCR Xencor	Biotechnology Engineered Monoclonal Antibodies	1.13B	12.4%	-	-62.6%	-	-41.0%
CVAC CureVac	Biotechnology MRNA Vaccines, Oncology Therapies	1.13B	83.9%	-	2.13%	5.08	66.2%
ORIC Oric	Biotechnology ORIC-114, ORIC-944, ORIC-533	1.13B	35.0%	-	57.3%	-	3.20%
TYRA Tyra Biosciences	Biotechnology Precision Medicine Platform, FGFR	1.13B	28.9%	-	49.9%	-	19.9%
PHARM Pharming	Biotechnology RUCONEST, Joenja, OTL-105	1.13B	66.8%	-	46.5%	-	81.4%
PVLA Palvella	Biotechnology Topical Rapamycin Gel, Microcystic	1.11B	25.5%	-	36.4%	-	417%
OCS Oculis Holding	Biotechnology OCS-01, OCS-02, OCS-05	1.11B	25.3%	-	57.2%	-	1.86%
ANAB AnaptysBio	Biotechnology Antibody, Autoimmune	1.11B	24.4%	-	50.8%	-	46.1%
CSTL Castle Biosciences	Biotechnology Melanoma, Squamous, Uveal	1.11B	53.6%	-	25.9%	-	14.2%
MNMD Mind Medicine	Biotechnology MM120, MM402, Anxiety, ADHD, Autism	1.06B	31.4%	-	67.6%	-	27.5%
NVAX Novavax	Biotechnology Vaccine, Adjuvant, Nanoparticle	1.05B	40.4%	-	-50.9%	3.22	-29.8%
ABCL Abcellera Biologics	Biotechnology Antibody, Metabolic, Autoimmune	1.05B	15.7%	-	-23.1%	-	5.61%
OPK Opko Health	Biotechnology Diagnostics, Laboratory-Testing	1.05B	21.0%	-	-37.3%	-	-26.2%
KOD Kodiak Sciences	Biotechnology Anti-VEGF, Biopolymer Conjugate	1.04B	46.1%	-	48.1%	-	198%
KURA Kura Oncology	Biotechnology Menin Inhibitor, Farnesyl	1.02B	53.8%	-	-20.5%	-	-6.56%
NBTX Nanobiotix	Biotechnology Nanoparticles, Radiotherapy	1.01B	48.8%	-	76.4%	-	430%
NANO Nanobiotix S.A	Biotechnology Nanoparticle, Radiotherapy	1.01B	36.1%	-	73.7%	-	379%
MDXG MiMedx	Biotechnology Placental Allografts, Wound Care	1.00B	86.1%	-	12.5%	25.1	-36.5%
SVRA Savara	Biotechnology Molgramostim, Proteinosis	1.00B	22.1%	-	73.5%	-	34.5%
BCAX Bicara	Biotechnology Ficerafusp Alfa, Bifunctional	988M	29.8%	-	-4.91%	3.35	-21.1%
MLTX MoonLake	Biotechnology Nanobody, IL-17A, IL-17F	978M	26.9%	-	7.91%	-	-77.9%
CDNA CareDx	Biotechnology AlloSure, AlloMap, AlloSeq	956M	50.3%	-	-26.2%	14.0	-37.8%
NTLA Intellia	Biotechnology In-Vivo CRISPR, CAR-T, NK Cell	951M	32.6%	-	-64.1%	-	-51.2%
GLUE Monte Rosa	Biotechnology MRT-2359, MRT-6160, MRT-8102, CDK2	926M	71.4%	-	27.0%	44.4	52.8%
RZLT Rezolute	Biotechnology Antibody, Hyperinsulinism	912M	37.0%	-	71.7%	-	66.8%
IOVA Iovance	Biotechnology Amtagvi, Proleukin, Lifileucel	889M	42.7%	-	-79.8%	-	-77.4%
SANA Sana Biotechnology	Biotechnology Allogeneic Islet Therapy, CAR-T	876M	35.2%	-	12.0%	-	37.2%
DAWN Day One	Biotechnology Tovorafenib, DAY301, VRK1 Inhibitor	875M	30.8%	-	-68.5%	-	-40.3%
GHRS GH Research	Biotechnology Mebufotenin, Depression	869M	24.6%	-	41.8%	-	38.4%
LENZ LENZ Therapeutics	Biotechnology Ophthalmic, Presbyopia, Clinical	867M	39.5%	1.0%	21.8%	-	-28.3%
CMPX Compass	Biotechnology Tovecimig, CTX-471, CTX-8371	866M	32.6%	-	34.6%	-	201%
VIR Vir Biotechnology	Biotechnology HDV, RSV, HPV, Coronavirus, TCE	851M	28.5%	-	-77.3%	-	-29.2%
AVBP ArriVent	Biotechnology Firmonertinib, ARR-217, ARR-002	840M	40.1%	-	-4.99%	-	-31.1%
RIGL Rigel	Biotechnology Kinase, Inhibitor	839M	92.6%	-	68.6%	7.47	59.1%
ABUS Arbutus Biopharma	Biotechnology RNAi Therapeutic, PD-L1 Inhibitor	829M	29.1%	-	60.4%	-	10.6%
ERAS Erasca	Biotechnology Naporafenib, ERAS-0015, ERAS-4001	828M	34.9%	-	-41.4%	-	-6.69%
IVA Inventiva S.A	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	800M	46.1%	-	13.9%	-	31.3%
ALMS Alumis	Biotechnology TYK2 Inhibitor, Psoriasis, Lupus	762M	50.9%	-	-74.6%	-	-31.6%
VLA Valneva SE	Biotechnology Japanese Encephalitis, Cholera	751M	20.9%	-	-3.62%	-	92.2%
RAPT RAPT Therapeutics	Biotechnology CCR4 Antagonist, Inflammation	750M	27.9%	-	-23.8%	-	162%
SPRY ARS	Biotechnology Epinephrine, Nasal Spray	750M	29.8%	-	4.22%	-	-42.7%
ESPR Esperion	Biotechnology Cholesterol-Lowering Tablets	730M	55.2%	-	-18.7%	-	35.4%
REPL Replimune	Biotechnology Oncolytic Immunotherapy, RP1, RP2	722M	28.2%	-	-72.8%	-	-37.7%
GERN Geron	Biotechnology Telomerase Inhibitor	715M	27.3%	-	-63.6%	-	-75.2%
ATXS Astria Therapeutics	Biotechnology Monoclonal, Antibody, Plasma	711M	35.6%	-	9.49%	-	4.45%
ORGO Organogenesis	Biotechnology Wound Care, Surgical Matrix	709M	30.4%	-	46.2%	-	21.0%
GOSS Gossamer Bio	Biotechnology Seralutinib, GB002, PAH Therapy	708M	36.0%	-	-3.86%	-	314%
LXEO Lexeo	Biotechnology Gene Therapy, Cardiomyopathy	692M	33.8%	-	-5.39%	-	7.06%
KALV Kalvista	Biotechnology Plasma Kallikrein Inhibitors, Oral	675M	39.7%	-	62.4%	-	21.6%
PRME Prime Medicine	Biotechnology Gene Editing, Prime Editing	672M	40.6%	-	-29.4%	-	-2.14%
CRVS Corvus	Biotechnology Kinase Inhibitor, Adenosine	665M	33.9%	-	57.2%	-	-16.2%
CTMX CytomX Therapeutics	Biotechnology Antibody-Drug Conjugate, T-Cell	657M	61.5%	-	52.6%	12.9	260%
ANNX Annexon	Biotechnology Antibody, Fragment	636M	36.7%	-	-35.4%	-	-29.6%
PROK ProKidney	Biotechnology Cell Therapy, Renal Cells	629M	40.8%	-	-27.8%	-	-0.25%
FDMT 4D Molecular	Biotechnology Ophthalmology, Cystic-Fibrosis	619M	27.5%	-	-18.6%	-	21.6%
VSTM Verastem	Biotechnology Avutometinib, Defactinib	611M	37.7%	-	47.7%	-	102%
MGTX MeiraGTx Holdings	Biotechnology Gene Therapies, Retinal Diseases	600M	36.3%	-	31.2%	-	8.97%
MYGN Myriad Genetics	Biotechnology Hereditary Cancer, Companion	600M	35.6%	0.08%	-76.7%	-	-59.4%
RGNX Regenxbio	Biotechnology Gene,Therapy,AAV,Platform,Pipeline	597M	14.5%	-	-14.9%	-	15.3%
ASMB Assembly	Biotechnology Antiviral, Small-Molecule	592M	33.9%	-	57.6%	-	92.4%
IVVD Invivyd	Biotechnology Antibody, Monoclonal, Covid	583M	40.4%	-	20.0%	-	201%
PRTA Prothena	Biotechnology Neurodegeneration, Antibody	564M	28.3%	-	-73.5%	-	-42.8%

ABBV
AbbVie

Biotechnology
Biologics, Immunology, Oncology

406B

48.0%

68.7%

84.4%

175

12.0%

AMGN
Amgen

Biotechnology
Rheumatoid Arthritis, Psoriasis

181B

82.1%

67.8%

56.7%

26.0

10.6%

GILD
Gilead Sciences

Biotechnology
Antivirals, Oncology, Hepatitis

155B

83.2%

65.3%

86.8%

19.4

23.7%

VRTX
Vertex

Biotechnology
Cystic Fibrosis, Sickle Cell, Beta

109B

87.0%

-

20.2%

30.0

-19.0%

REGN
Regeneron

Biotechnology
Eylea, Dupixent, Libtayo

78.1B

75.7%

14.8%

-4.55%

17.7

-9.02%

ALNY
Alnylam

Biotechnology
RNAi Therapeutics, Patisiran

57.4B

61.7%

-

85.7%

-

52.7%

ARGX
argenx

Biotechnology
Antibody,Autoimmune,Therapy,FcRn,Ig..

57.2B

71.2%

-

80.5%

39.2

30.0%

HLN
Haleon

Biotechnology
Toothpaste, Vitamins, Pain-Relief

44.0B

60.1%

53.3%

46.4%

22.3

-11.0%

INSM
Insmed

Biotechnology
Inhaled Antibiotic, DPP1

42.4B

32.5%

-

86.9%

-

135%

ONC
BeiGene

Biotechnology
BTK-Inhibitor, Anti-PD-1

38.7B

64.5%

-

64.3%

659

43.8%

NTRA
Natera

Biotechnology
Prenatal Screening, Carrier

31.8B

47.9%

-

70.0%

-

22.5%

BIIB
Biogen

Biotechnology
Multiple Sclerosis Therapies

25.9B

66.7%

-

-33.2%

16.1

-0.91%

BNTX
BioNTech SE

Biotechnology
Oncology Vaccines,Checkpoint

24.7B

13.6%

1.0%

-54.4%

-

-26.0%

22UA
BioNTech SE

Biotechnology
Cancer Vaccines, mRNA Therapies

23.9B

17.5%

1.0%

-64.7%

-

-32.9%

UTHR
United Therapeutics

Biotechnology
Treprostinil, Treprostinil

22.0B

92.2%

-

66.7%

18.1

12.4%

INCY
Incyte

Biotechnology
JAKAFI, MONJUVI, PEMAZYRE

19.9B

90.2%

-

36.0%

17.2

21.9%

GMAB
Genmab AS

Biotechnology
Antibody, Cancer, Lymphoma

18.8B

78.6%

-

-1.13%

13.4

31.3%

BIM
Biomerieux

Biotechnology
Diagnostic, Instruments, Reagents

15.0B

78.1%

60.3%

29.7%

34.6

-3.35%

ROIV
Roivant Sciences

Biotechnology
Antibody, Small-Molecule, Inhaled

14.1B

31.3%

-

82.7%

-

43.2%

NBIX
Neurocrine

Biotechnology
Movement, Endocrine

14.1B

85.8%

-

40.7%

33.6

4.23%

RVMD
Revolution

Biotechnology
RAS Inhibitors, Companion

13.7B

24.6%

-

59.5%

-

15.3%

MDGL
Madrigal

Biotechnology
Rezdiffra, Liver Therapy, MASH

13.4B

55.5%

-

83.2%

-

57.8%

EXAS
EXACT Sciences

Biotechnology
Colorectal, Breast, Colon

13.2B

47.5%

-

33.7%

-

43.2%

ASND
Ascendis Pharma AS

Biotechnology
Growth Hormone

12.9B

35.9%

-

77.1%

-

34.1%

BBIO
BridgeBio Pharma

Biotechnology
ATTR Medication, FGFR Inhibitor

12.5B

48.7%

-

83.1%

-

127%

SMMT
Summit Therapeutics

Biotechnology
Antibody, Immunotherapy, Oncology

12.3B

43.1%

-

49.9%

-

-18.1%

ERF
Eurofins

Biotechnology
Testing, Laboratory, Services

12.1B

70.1%

2.73%

16.7%

26.0

10.2%

IONS
Ionis

Biotechnology
Triglyceride, Amyloidosis, SMA

12.1B

19.7%

0.21%

70.0%

-

101%

EXEL
Exelixis

Biotechnology
Cabozantinib, Cobimetinib

11.3B

93.1%

-

81.1%

17.7

7.10%

RNA
Avidity Biosciences

Biotechnology
Antibody-Oligonucleotide

10.7B

33.3%

-

80.6%

-

43.8%

BMRN
Biomarin

Biotechnology
Enzyme replacement therapy

10.4B

86.1%

-

-70.4%

20.1

-26.1%

MRNA
Moderna

Biotechnology
Respiratory Vaccines, Latent

9.44B

22.3%

-

-85.9%

-

-49.8%

HALO
Halozyme

Biotechnology
Enzyme, Cancer, Immunodeficiency

8.26B

92.1%

-

51.9%

14.8

30.5%

ABVX
Abivax American

Biotechnology
Obefazimod, Immunoregulatory

8.19B

38.7%

-

76.5%

-

1,178%

ABVX
Abivax

Biotechnology
Drug, Phase3, Ulcerative, Crohns

8.08B

42.5%

-

69.5%

-

1,110%

CYTK
Cytokinetics

Biotechnology
Cardiac Activator, Skeletal

7.76B

35.7%

-

39.8%

-

13.6%

NUVL
Nuvalent

Biotechnology
ROS1 Inhibitor, ALK Inhibitor

7.70B

28.9%

-

69.7%

-

-1.89%

GRFS
Grifols

Biotechnology
Immunoglobulin, Albumin

7.65B

68.4%

40.8%

19.8%

13.8

-3.73%

MRUS
Merus BV

Biotechnology
Bispecific Antibodies, BIZENGRI

7.28B

28.7%

-

92.1%

-

86.0%

CDTX
Cidara Therapeutics

Biotechnology
Antifungal, Antiviral, Oncology

6.90B

23.5%

-

78.0%

-

847%

RYTM
Rhythm

Biotechnology
Setmelanotide, Rare Obesity, MC4R

6.79B

43.0%

-

93.2%

-

50.2%

PCVX
Vaxcyte

Biotechnology
Pneumococcal, Streptococcus

6.25B

27.0%

-

-10.4%

-

-54.0%

RGC
Regencell

Biotechnology
Traditional Chinese Medicine

6.24B

36.4%

-

78.2%

-

6,036%

PTCT
PTC Therapeutics

Biotechnology
Translarna, Emflaza, Upstaza

6.07B

65.6%

-

60.6%

8.93

66.4%

KRYS
Krystal Biotech

Biotechnology
Gene, Therapy, Topical, Wound, Skin

5.93B

89.1%

-

62.0%

30.7

-3.32%

ARWR
Arrowhead

Biotechnology
Plozasiran, Olpasiran, Fazirsiran

5.59B

33.1%

-

37.3%

-

92.1%

PTGX
Protagonist

Biotechnology
Peptide, Hematology, Inflammation

5.34B

64.0%

-

89.4%

129

74.4%

COGT
Cogent Biosciences

Biotechnology
Kinase Inhibitor, FGFR Inhibitor

5.33B

49.3%

-

65.2%

-

267%

ACLX
Arcellx

Biotechnology
Anitocabtagene Autoleucel

5.24B

40.5%

-

63.6%

-

-28.4%

LEGN
Legend Biotech

Biotechnology
CAR-T, Oncology, Myeloma

5.20B

30.1%

-

-51.0%

-

-44.5%

TGTX
TG Therapeutics

Biotechnology
Anti-CD20 Antibody, BTK Inhibitor

5.09B

67.4%

-

39.7%

11.6

-16.9%

ALKS
Alkermes

Biotechnology
Schizophrenia, Bipolar, Alcohol

4.83B

89.7%

-

10.7%

14.6

-11.8%

CRSP
Crispr Therapeutics

Biotechnology
Gene-Edited Cell Therapy, CAR T

4.79B

31.3%

-

9.42%

-

-8.74%

KYMR
Kymera Therapeutics

Biotechnology
IRAK4, STAT6, TYK2, Protein

4.65B

29.0%

-

60.2%

-

26.1%

APGE
Apogee

Biotechnology
Monoclonal Antibody, Atopic

4.53B

35.0%

-

61.2%

-

37.1%

CELC
Celcuity

Biotechnology
Cancer Test, Therapy Candidate

4.36B

24.7%

-

78.3%

-

580%

NAMS
NewAmsterdam

Biotechnology
Obicetrapib, Ezetimibe, CETP

4.34B

27.1%

-

82.4%

-

73.5%

VKTX
Viking Therapeutics

Biotechnology
VK2809, VK2735, VK5211, VK0214

4.27B

40.8%

-

48.3%

-

-42.1%

PRAX
Praxis Precision

Biotechnology
Ulixacaltamide, Vormatrigine

4.25B

30.5%

-

46.0%

-

107%

BLTE
Belite Bio

Biotechnology
Oral Therapy, Stargardt

4.21B

32.1%

-

86.1%

-

67.3%

ADMA
ADMA Biologics

Biotechnology
IVIG, Immune Globulin, Hepatitis

4.10B

85.0%

-

41.6%

20.0

-23.7%

IMVT
Immunovant

Biotechnology
Monoclonal Antibodies, Autoimmune

4.09B

25.8%

-

17.4%

-

-28.2%

CRNX
Crinetics

Biotechnology
Paltusotine, Atumelnant, CRN09682

4.07B

21.7%

-

45.9%

-

-30.5%

INDV
Indivior Ordinary

Biotechnology
Suboxone, Sublocade, Subutex, Opvee

4.03B

74.1%

2.63%

61.6%

32.9

157%

CNTA
Centessa

Biotechnology
Sleep Disorder Drug

4.02B

33.3%

-

71.7%

-

43.3%

ACAD
ACADIA

Biotechnology
Parkinsons Psychosis Drug, Rett

3.99B

86.7%

-

53.0%

15.2

32.6%

LGND
Ligand

Biotechnology
Infectious, Oncology, Nephrology

3.92B

52.2%

0.14%

82.7%

87.7

46.4%

SRRK
Scholar Rock

Biotechnology
Monoclonal Antibodies, Inhibitor

3.88B

25.9%

-

35.6%

-

-1.55%

GRAL
GRAIL

Biotechnology
Cancer Screening, Diagnostic Aid

3.65B

40.1%

-

91.6%

-

450%

ARQT
Arcutis

Biotechnology
Topical Cream, Topical Foam, JAK1

3.61B

41.9%

-

50.8%

-

130%

MIRM
Mirum

Biotechnology
LIVMARLI, Cholbam, Chenodal

3.55B

48.2%

-

91.9%

-

36.5%

IRON
Disc Medicine

Biotechnology
Porphyria Drug, Anemia Drug

3.50B

36.3%

-

46.4%

-

26.4%

VCYT
Veracyte

Biotechnology
Thyroid, Prostate, Bladder

3.48B

63.3%

-

20.5%

116

-3.17%

CGON
CG Oncology

Biotechnology
Oncolytic Immunotherapy

3.42B

32.2%

-

26.4%

-

14.5%

MLYS
Mineralys

Biotechnology
Phase II Inhibitor, Oral

3.31B

31.1%

-

74.5%

-

188%

RARE
Ultragenyx

Biotechnology
Biologic, Gene Therapy, Antibody

3.24B

36.5%

-

-52.3%

-

-38.9%

XENE
Xenon

Biotechnology
Kv7 Opener, Phase 3, Epilepsy

3.18B

29.2%

-

22.0%

-

-10.3%

KNSA
Kiniksa

Biotechnology
ARCALYST, Vixarelimab, KPL-387

3.13B

67.0%

-

92.4%

91.7

65.9%

IDYA
Ideaya Biosciences

Biotechnology
Oncology, Kinase, Inhibitor, ADC

3.11B

22.9%

-

59.9%

-

15.7%

TVTX
Travere

Biotechnology
Medication, Tablets, Enzyme

3.11B

27.7%

-

41.4%

-

68.8%

FOLD
Amicus Therapeutics

Biotechnology
Galafold, Pombiliti, Opfolda, Gene

2.95B

52.6%

-

-28.6%

-

-12.4%

DYN
Dyne Therapeutics

Biotechnology
Therapeutics, Muscular Dystrophy

2.94B

29.6%

-

18.6%

-

-40.8%

CPRX
Catalyst

Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree

2.86B

91.5%

-

23.9%

13.6

-8.71%

DNLI
Denali Therapeutics

Biotechnology
RIPK1 Inhibitor, LRRK2 Inhibitor

2.78B

25.0%

-

-58.2%

-

-32.9%

VRDN
Viridian

Biotechnology
Monoclonal Antibody, Thyroid Eye

2.77B

46.9%

-

28.6%

-

26.3%

APLS
Apellis

Biotechnology
Therapeutic, Complement

2.48B

76.8%

-

-62.6%

54.5

-45.0%

RCUS
Arcus Biosciences

Biotechnology
HIF-2a-Inhibitor

2.47B

29.5%

-

-17.9%

-

40.8%

SLNO
Soleno Therapeutics

Biotechnology
Diazoxide, Choline, Tablet, Rare

2.42B

41.4%

-

61.9%

-

-22.8%

EWTX
Edgewise

Biotechnology
Muscle Disorder Therapies

2.40B

29.8%

-

16.7%

-

-31.0%

NUVB
Nuvation Bio

Biotechnology
Oncology Pipeline Drug Candidates

2.40B

35.6%

-

60.8%

-

141%

NNNN
Anbio

Biotechnology
Antigen Tests, Immunoassay

2.32B

66.8%

-

85.0%

858

250%

BEAM
Beam Therapeutics

Biotechnology
Base-Editing Therapeutics, Sickle

2.25B

28.0%

-

-56.0%

-

-19.9%

ZLAB
Zai Lab

Biotechnology
Oncology, Immunology

2.22B

30.9%

-

-48.3%

-

-38.2%

RXRX
Recursion

Biotechnology
Drug Discovery Platform

2.17B

30.1%

-

-70.9%

-

-39.8%

AUPH
Aurinia

Biotechnology
Immunosuppressant, Lupus

2.12B

93.8%

-

61.3%

28.8

61.0%

IBRX
Immunitybio

Biotechnology
Immunotherapy, Vaccine, Cytokine

2.12B

65.8%

-

-74.8%

-

-63.7%

GPCR
Structure

Biotechnology
GSBR-1290, ACCG-2671, ANPA-0073

2.08B

31.2%

-

25.8%

-

-11.7%

GLPG
Galapagos

Biotechnology
CAR-T, Oncology, Immunology

2.03B

25.3%

-

-17.2%

-

-12.4%

GLPG
Galapagos

Biotechnology
Medicine, Oncology, Immunology

2.02B

37.8%

-

-1.60%

-

-3.64%

VCEL
Vericel Ord

Biotechnology
Cartilage, Skin, Burn, Autologous

2.00B

61.7%

-

-0.83%

152

-39.2%

IMCR
Immunocore Holdings

Biotechnology
Oncology Immunotherapy

1.99B

41.7%

-

3.45%

-

6.40%

SION
Sionna

Biotechnology
Galicaftor, Navocaftor, SION-109

1.95B

37.1%

-

91.2%

-

115%

MESO
Mesoblast

Biotechnology
Stem-Cell Therapy, Inflammation

1.94B

31.5%

-

41.1%

-

30.6%

ZBIO
Zenas BioPharma

Biotechnology
Bifunctional Monoclonal Antibody

1.91B

31.4%

-

85.6%

2.61

200%

SYRE
Spyre Therapeutics

Biotechnology
Monoclonal Antibodies

1.88B

28.5%

-

22.0%

-

-6.68%

SRPT
Sarepta

Biotechnology
RNA Therapeutics, Duchenne

1.83B

30.3%

-

-76.8%

-

-86.8%

OLMA
Olema

Biotechnology
Palazestrant, OP-3136, KAT6

1.82B

33.9%

-

59.9%

-

142%

VERA
Vera Therapeutics

Biotechnology
Atacicept, Mab, Dual-Inhibitor

1.82B

23.4%

3.50%

17.2%

-

-40.6%

ZYME
Zymeworks Common

Biotechnology
Zanidatamab, Bispecific Antibody

1.80B

28.6%

-

66.5%

-

65.0%

DNTH
Dianthus

Biotechnology
Monoclonal Antibody, DNTH103

1.78B

27.9%

-

46.3%

-

60.8%

JANX
Janux Therapeutics

Biotechnology
JANX007, JANX008, TRACTr, TRACIr

1.73B

28.6%

-

9.93%

-

-34.9%

QURE
Uniqure

Biotechnology
Gene Therapy, Hemophilia Treatment

1.73B

36.0%

-

19.7%

-

300%

CLDX
Celldex

Biotechnology
Monoclonal Antibody, Bispecific

1.72B

40.4%

-

-22.1%

-

-16.4%

ALVO
Alvotech

Biotechnology
Biosimilar, Autoimmune, Oncology

1.72B

36.6%

-

-45.5%

24.0

-61.6%

PHVS
Pharvaris BV

Biotechnology
Bradykinin, Antagonist

1.61B

24.4%

-

72.6%

-

7.91%

IMNM
Immunome

Biotechnology
Antibody, Oncology, Bispecific

1.61B

45.2%

-

57.4%

-

20.4%

STOK
Stoke Therapeutics

Biotechnology
STK-002,Zorevunersen,ASOs,TANGO,Gen..

1.60B

73.3%

-

66.8%

41.1

128%

TWST
Twist Bioscience

Biotechnology
Synthetic DNA, Gene Fragments

1.59B

35.7%

-

-35.3%

-

-42.9%

MNKD
MannKind

Biotechnology
Inhaled Insulin, Insulin Delivery

1.56B

64.2%

-

-4.59%

50.7

-29.2%

AGIO
Agios Pharm

Biotechnology
Mitapivat, Tebapivat, AG-181

1.54B

34.6%

-

-2.47%

-

-56.9%

SNDX
Syndax

Biotechnology
Menin Inhibitor, CSF-1R Antibody

1.52B

36.6%

-

-11.9%

-

4.76%

MEDCL
Medincell

Biotechnology
Schizophrenia, Postoperative Pain

1.48B

53.3%

-

81.8%

-

40.0%

BCRX
BioCryst

Biotechnology
Antiviral Injection, Oral HAE

1.47B

71.6%

-

-41.3%

-

-17.6%

ATAI
ATAI Life Sciences

Biotechnology
Psychedelic, Intranasal, Oral

1.38B

37.9%

-

32.1%

-

88.7%

PGEN
Precigen

Biotechnology
UltraCAR-T, AdenoVerse, PRGN-3005

1.36B

34.7%

-

55.9%

-

258%

TNGX
Tango Therapeutics

Biotechnology
PRMT5 Inhibitor, Glioblastoma

1.35B

33.2%

-

39.6%

-

130%

DVAX
Dynavax

Biotechnology
Hepatitis Vaccine, Adjuvant

1.34B

38.0%

-

-29.8%

-

-22.9%

ARDX
Ardelyx

Biotechnology
IBS-C Therapy, Phosphate

1.34B

33.6%

-

45.6%

-

-9.28%

ORKA
Oruka Therapeutics

Biotechnology
Monoclonal Antibody

1.33B

28.8%

1.0%

49.9%

-

30.9%

BTX
BlackRock

Biotechnology
Technology, Private, Equity

1.32B

33.5%

87.9%

13.5%

51.8

-15.6%

BHVN
Biohaven

Biotechnology
Troriluzole, Taldefgrobep

1.29B

31.9%

-

-62.3%

-

-82.2%

NRIX
Nurix Therapeutics

Biotechnology
BTK Degrader, IRAK4 Degrader

1.29B

35.0%

-

-16.0%

-

-29.5%

UPB
Upstream Bio

Biotechnology
Verekitug, Asthma, Rhinosinusitis

1.26B

38.0%

-

61.5%

-

14.6%

IMTX
Immatics

Biotechnology
TCR-Engineered Cell Therapy, TCR

1.24B

22.0%

-

11.5%

-

16.8%

MBX
MBX Biosciences

Biotechnology
Hypoparathyroidism, Hypoglycemia

1.22B

31.8%

-

62.2%

3.53

40.4%

RLAY
Relay Therapeutics

Biotechnology
PI3Ka Inhibitor, Estrogen

1.17B

47.4%

-

-27.5%

-

45.6%

URGN
UroGen Pharma

Biotechnology
Jelmyto, UGN-102, UGN-103

1.16B

48.5%

-

69.1%

-

102%

TSHA
Taysha Gene

Biotechnology
Gene, Therapy, AAV, CNS, Monogenic

1.15B

45.7%

-

54.6%

-

41.0%

XNCR
Xencor

Biotechnology
Engineered Monoclonal Antibodies

1.13B

12.4%

-

-62.6%

-

-41.0%

CVAC
CureVac

Biotechnology
MRNA Vaccines, Oncology Therapies

1.13B

83.9%

-

2.13%

5.08

66.2%

ORIC
Oric

Biotechnology
ORIC-114, ORIC-944, ORIC-533

1.13B

35.0%

-

57.3%

-

3.20%

TYRA
Tyra Biosciences

Biotechnology
Precision Medicine Platform, FGFR

1.13B

28.9%

-

49.9%

-

19.9%

PHARM
Pharming

Biotechnology
RUCONEST, Joenja, OTL-105

1.13B

66.8%

-

46.5%

-

81.4%

PVLA
Palvella

Biotechnology
Topical Rapamycin Gel, Microcystic

1.11B

25.5%

-

36.4%

-

417%

OCS
Oculis Holding

Biotechnology
OCS-01, OCS-02, OCS-05

1.11B

25.3%

-

57.2%

-

1.86%

ANAB
AnaptysBio

Biotechnology
Antibody, Autoimmune

1.11B

24.4%

-

50.8%

-

46.1%

CSTL
Castle Biosciences

Biotechnology
Melanoma, Squamous, Uveal

1.11B

53.6%

-

25.9%

-

14.2%

MNMD
Mind Medicine

Biotechnology
MM120, MM402, Anxiety, ADHD, Autism

1.06B

31.4%

-

67.6%

-

27.5%

NVAX
Novavax

Biotechnology
Vaccine, Adjuvant, Nanoparticle

1.05B

40.4%

-

-50.9%

3.22

-29.8%

ABCL
Abcellera Biologics

Biotechnology
Antibody, Metabolic, Autoimmune

1.05B

15.7%

-

-23.1%

-

5.61%

OPK
Opko Health

Biotechnology
Diagnostics, Laboratory-Testing

1.05B

21.0%

-

-37.3%

-

-26.2%

KOD
Kodiak Sciences

Biotechnology
Anti-VEGF, Biopolymer Conjugate

1.04B

46.1%

-

48.1%

-

198%

KURA
Kura Oncology

Biotechnology
Menin Inhibitor, Farnesyl

1.02B

53.8%

-

-20.5%

-

-6.56%

NBTX
Nanobiotix

Biotechnology
Nanoparticles, Radiotherapy

1.01B

48.8%

-

76.4%

-

430%

NANO
Nanobiotix S.A

Biotechnology
Nanoparticle, Radiotherapy

1.01B

36.1%

-

73.7%

-

379%

MDXG
MiMedx

Biotechnology
Placental Allografts, Wound Care

1.00B

86.1%

-

12.5%

25.1

-36.5%

SVRA
Savara

Biotechnology
Molgramostim, Proteinosis

1.00B

22.1%

-

73.5%

-

34.5%

BCAX
Bicara

Biotechnology
Ficerafusp Alfa, Bifunctional

988M

29.8%

-

-4.91%

3.35

-21.1%

MLTX
MoonLake

Biotechnology
Nanobody, IL-17A, IL-17F

978M

26.9%

-

7.91%

-

-77.9%

CDNA
CareDx

Biotechnology
AlloSure, AlloMap, AlloSeq

956M

50.3%

-

-26.2%

14.0

-37.8%

NTLA
Intellia

Biotechnology
In-Vivo CRISPR, CAR-T, NK Cell

951M

32.6%

-

-64.1%

-

-51.2%

GLUE
Monte Rosa

Biotechnology
MRT-2359, MRT-6160, MRT-8102, CDK2

926M

71.4%

-

27.0%

44.4

52.8%

RZLT
Rezolute

Biotechnology
Antibody, Hyperinsulinism

912M

37.0%

-

71.7%

-

66.8%

IOVA
Iovance

Biotechnology
Amtagvi, Proleukin, Lifileucel

889M

42.7%

-

-79.8%

-

-77.4%

SANA
Sana Biotechnology

Biotechnology
Allogeneic Islet Therapy, CAR-T

876M

35.2%

-

12.0%

-

37.2%

DAWN
Day One

Biotechnology
Tovorafenib, DAY301, VRK1 Inhibitor

875M

30.8%

-

-68.5%

-

-40.3%

GHRS
GH Research

Biotechnology
Mebufotenin, Depression

869M

24.6%

-

41.8%

-

38.4%

LENZ
LENZ Therapeutics

Biotechnology
Ophthalmic, Presbyopia, Clinical

867M

39.5%

1.0%

21.8%

-

-28.3%

CMPX
Compass

Biotechnology
Tovecimig, CTX-471, CTX-8371

866M

32.6%

-

34.6%

-

201%

VIR
Vir Biotechnology

Biotechnology
HDV, RSV, HPV, Coronavirus, TCE

851M

28.5%

-

-77.3%

-

-29.2%

AVBP
ArriVent

Biotechnology
Firmonertinib, ARR-217, ARR-002

840M

40.1%

-

-4.99%

-

-31.1%

RIGL
Rigel

Biotechnology
Kinase, Inhibitor

839M

92.6%

-

68.6%

7.47

59.1%

ABUS
Arbutus Biopharma

Biotechnology
RNAi Therapeutic, PD-L1 Inhibitor

829M

29.1%

-

60.4%

-

10.6%

ERAS
Erasca

Biotechnology
Naporafenib, ERAS-0015, ERAS-4001

828M

34.9%

-

-41.4%

-

-6.69%

IVA
Inventiva S.A

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

800M

46.1%

-

13.9%

-

31.3%

ALMS
Alumis

Biotechnology
TYK2 Inhibitor, Psoriasis, Lupus

762M

50.9%

-

-74.6%

-

-31.6%

VLA
Valneva SE

Biotechnology
Japanese Encephalitis, Cholera

751M

20.9%

-

-3.62%

-

92.2%

RAPT
RAPT Therapeutics

Biotechnology
CCR4 Antagonist, Inflammation

750M

27.9%

-

-23.8%

-

162%

SPRY
ARS

Biotechnology
Epinephrine, Nasal Spray

750M

29.8%

-

4.22%

-

-42.7%

ESPR
Esperion

Biotechnology
Cholesterol-Lowering Tablets

730M

55.2%

-

-18.7%

-

35.4%

REPL
Replimune

Biotechnology
Oncolytic Immunotherapy, RP1, RP2

722M

28.2%

-

-72.8%

-

-37.7%

GERN
Geron

Biotechnology
Telomerase Inhibitor

715M

27.3%

-

-63.6%

-

-75.2%

ATXS
Astria Therapeutics

Biotechnology
Monoclonal, Antibody, Plasma

711M

35.6%

-

9.49%

-

4.45%

ORGO
Organogenesis

Biotechnology
Wound Care, Surgical Matrix

709M

30.4%

-

46.2%

-

21.0%

GOSS
Gossamer Bio

Biotechnology
Seralutinib, GB002, PAH Therapy

708M

36.0%

-

-3.86%

-

314%

LXEO
Lexeo

Biotechnology
Gene Therapy, Cardiomyopathy

692M

33.8%

-

-5.39%

-

7.06%

KALV
Kalvista

Biotechnology
Plasma Kallikrein Inhibitors, Oral

675M

39.7%

-

62.4%

-

21.6%

PRME
Prime Medicine

Biotechnology
Gene Editing, Prime Editing

672M

40.6%

-

-29.4%

-

-2.14%

CRVS
Corvus

Biotechnology
Kinase Inhibitor, Adenosine

665M

33.9%

-

57.2%

-

-16.2%

CTMX
CytomX Therapeutics

Biotechnology
Antibody-Drug Conjugate, T-Cell

657M

61.5%

-

52.6%

12.9

260%

ANNX
Annexon

Biotechnology
Antibody, Fragment

636M

36.7%

-

-35.4%

-

-29.6%

PROK
ProKidney

Biotechnology
Cell Therapy, Renal Cells

629M

40.8%

-

-27.8%

-

-0.25%

FDMT
4D Molecular

Biotechnology
Ophthalmology, Cystic-Fibrosis

619M

27.5%

-

-18.6%

-

21.6%

VSTM
Verastem

Biotechnology
Avutometinib, Defactinib

611M

37.7%

-

47.7%

-

102%

MGTX
MeiraGTx Holdings

Biotechnology
Gene Therapies, Retinal Diseases

600M

36.3%

-

31.2%

-

8.97%

MYGN
Myriad Genetics

Biotechnology
Hereditary Cancer, Companion

600M

35.6%

0.08%

-76.7%

-

-59.4%

RGNX
Regenxbio

Biotechnology
Gene,Therapy,AAV,Platform,Pipeline

597M

14.5%

-

-14.9%

-

15.3%

ASMB
Assembly

Biotechnology
Antiviral, Small-Molecule

592M

33.9%

-

57.6%

-

92.4%

IVVD
Invivyd

Biotechnology
Antibody, Monoclonal, Covid

583M

40.4%

-

20.0%

-

201%

PRTA
Prothena

Biotechnology
Neurodegeneration, Antibody

564M

28.3%

-

-73.5%

-

-42.8%

Stocks & ETFs Screener: 200+ results (Biotechnology)

Basic Filter

Fundamental Filter

Benchmark

Performance/Technical